dc.date.accessioned2018-11-29T15:37:05Z
dc.date.accessioned2022-10-18T21:28:34Z
dc.date.available2018-11-29T15:37:05Z
dc.date.available2022-10-18T21:28:34Z
dc.date.created2018-11-29T15:37:05Z
dc.identifierhttp://hdl.handle.net/10533/228645
dc.identifier1140412
dc.identifierWOS:000394102500006
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4460001
dc.languageeng
dc.relationhttps://aac.asm.org/content/61/2/e01290-16.long
dc.relationhandle/10533/111556
dc.relation10.1128/AAC.01290-16
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleHigh prevalence of pneumocystis jirovecii dihydropteroate synthase gene mutations in patients with a first episode of pneumocystis pneumonia in santiago, chile, and clinical response to trimethoprim-sulfamethoxazole therapy
dc.typeArticulo


Este ítem pertenece a la siguiente institución